Icon

PEMFEXY (nda209472)- (500MG/20ML (25MG/ML))

PEMETREXED EAGLE PHARMS
500MG/20ML (25MG/ML)
Yes Yes
2036-Feb-19 Expired
None None
None No
PEMFEXY is a folate analog metabolic inhibitor indicated for: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC). • as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. • as a single agent for the treatment of patients with recurrent, metastatic non-squamous NSCLC after prior chemotherapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
500MG/20ML (25MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.